H. B. Fuller Company (NYSE:FUL) has received a consensus rating of “Hold” from the eight ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation and seven have given a hold recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $59.33.

FUL has been the topic of a number of research reports. BidaskClub downgraded shares of H. B. Fuller from a “hold” rating to a “sell” rating in a report on Saturday, August 12th. Zacks Investment Research upgraded shares of H. B. Fuller from a “sell” rating to a “hold” rating in a report on Thursday, August 17th. KeyCorp restated a “hold” rating on shares of H. B. Fuller in a report on Thursday, August 24th. Deutsche Bank boosted their target price on shares of H. B. Fuller from $56.00 to $58.00 and gave the stock a “hold” rating in a report on Wednesday, September 6th. Finally, Robert W. Baird initiated coverage on shares of H. B. Fuller in a report on Thursday, September 14th. They issued a “neutral” rating and a $60.00 target price on the stock.

Shares of H. B. Fuller (FUL) opened at $55.65 on Monday. H. B. Fuller has a fifty-two week low of $46.09 and a fifty-two week high of $58.74. The company has a quick ratio of 1.72, a current ratio of 2.63 and a debt-to-equity ratio of 0.74. The firm has a market cap of $2,801.03, a PE ratio of 22.35 and a beta of 1.73.

H. B. Fuller (NYSE:FUL) last posted its earnings results on Wednesday, September 27th. The specialty chemicals company reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.67 by ($0.02). H. B. Fuller had a return on equity of 13.08% and a net margin of 4.76%. The business had revenue of $562.87 million during the quarter, compared to the consensus estimate of $553.66 million. research analysts anticipate that H. B. Fuller will post 2.6 earnings per share for the current year.

In related news, VP Timothy J. Keenan sold 6,500 shares of H. B. Fuller stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $55.08, for a total transaction of $358,020.00. Following the completion of the transaction, the vice president now directly owns 29,611 shares of the company’s stock, valued at approximately $1,630,973.88. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Robert J. Martsching sold 3,870 shares of H. B. Fuller stock in a transaction dated Monday, October 23rd. The stock was sold at an average price of $57.93, for a total transaction of $224,189.10. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,767 shares of company stock valued at $897,394. 3.10% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in FUL. Janus Henderson Group PLC purchased a new stake in H. B. Fuller in the 2nd quarter valued at about $105,912,000. Principal Financial Group Inc. boosted its position in H. B. Fuller by 141.0% in the 2nd quarter. Principal Financial Group Inc. now owns 977,899 shares of the specialty chemicals company’s stock valued at $49,980,000 after buying an additional 572,177 shares during the period. Westfield Capital Management Co. LP boosted its position in H. B. Fuller by 135.7% in the 3rd quarter. Westfield Capital Management Co. LP now owns 476,700 shares of the specialty chemicals company’s stock valued at $27,677,000 after buying an additional 274,433 shares during the period. Pioneer Investment Management Inc. purchased a new stake in H. B. Fuller in the 2nd quarter valued at about $11,091,000. Finally, Amundi Pioneer Asset Management Inc. boosted its position in H. B. Fuller by 92.4% in the 3rd quarter. Amundi Pioneer Asset Management Inc. now owns 417,610 shares of the specialty chemicals company’s stock valued at $24,247,000 after buying an additional 200,594 shares during the period. 92.34% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This report was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.americanbankingnews.com/2017/12/04/h-b-fuller-company-ful-receives-consensus-recommendation-of-hold-from-analysts.html.

About H. B. Fuller

H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. The Company’s segments include Americas Adhesives, Europe, India, Middle East and Africa (EIMEA), Asia Pacific, Construction Products and Engineering Adhesives. The Americas Adhesives, EIMEA and Asia Pacific operating segments produce and supply industrial adhesives products for applications in various markets, including durable assembly, nonwoven and hygiene, and textile.

Analyst Recommendations for H. B. Fuller (NYSE:FUL)

Receive News & Ratings for H. B. Fuller Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller Company and related companies with MarketBeat.com's FREE daily email newsletter.